The impact of idiopathic epilepsy on sleep quality in dogs: A replication study and validation of the SNoRE questionnaire in Ukraine

Authors

DOI:

https://doi.org/10.31210/spi2026.29.01.40

Keywords:

idiopathic epilepsy, dogs, sleep quality, Sleep and Nighttime Restlessness Evaluation questionnaire, antiseizure medications, translational research

Abstract

This replication study evaluated the specific characteristics of sleep quality in dogs diagnosed with idiopathic epilepsy compared to clinically healthy animals within the context of Ukrainian veterinary practice. The study is grounded in the hypothesis of a complex bidirectional relationship between epilepsy and sleep disorders, a phenomenon well-documented in human medicine but remaining insufficiently investigated in the veterinary field. The research was conducted between 2024 and 2025 at the "ANIMALIA" veterinary clinic in Dnipro, Ukraine. The study sample consisted of sixty-four dogs distributed into two equal groups using a case-control design: the main group (n=32) comprising dogs with a confirmed idiopathic epilepsy diagnosis matching the Tier II confidence level according to the International Veterinary Epilepsy Task Force guidelines, and a control group (n=32) of healthy dogs, strictly matched by age, sex, and breed characteristics. Data collection was performed using the owner-based validated Sleep and Nighttime Restlessness Evaluation questionnaire. The results revealed statistically significant differences in total sleep quality scores between the two groups. Dogs with idiopathic epilepsy demonstrated a significantly higher median total score of 12 with an interquartile range of 6–33, compared to a median score of 8 with an interquartile range of 6–22 in the control group (p<0.001), indicating substantial sleep impairment. Detailed factor analysis clarified that the decrease in sleep quality was driven exclusively by Factor 1 (Sleep Quality), which includes the ability to fall asleep and sleep continuity; the median score in the study group was 9 against 5 in the control group (p<0.001). Conversely, no significant differences were found for Factor 2 (Sleep Interruption due to Dreaming), with both groups showing a median score of 2 (p=0.99), suggesting the preservation of rapid eye movement sleep stability. Furthermore, the study investigated potential correlations with clinical variables. No statistically significant association was found between sleep quality scores and seizure frequency (p=0.73), the presence of cluster seizures (p=0.22), or the number and type of antiseizure medications administered (p=0.77). However, subjective owner reports indicated that 68.8% of dogs experience changes in sleep patterns during the postictal phase, with the majority (59.5 %) showing hypersomnia, likely reflecting a compensatory neural recovery mechanism. The findings confirm the clinical utility of the Sleep and Nighttime Restlessness Evaluation questionnaire as a sensitive screening tool for detecting non-motor comorbidities in canine epilepsy. The study highlights that sleep disturbances in dogs with idiopathic epilepsy should be regarded as an independent pathological feature rather than a direct consequence of pharmacotherapy. These results emphasize the necessity of integrating routine sleep assessment into standard management protocols for veterinary neurological patients to improve their overall quality of life.

References

1. Barry, M., Cameron, S., Kent, S., Barnes-Heller, H., & Grady, K. (2021). Daytime and nocturnal activity in treated dogs with idiopathic epilepsy compared to matched unaffected controls. Journal of Veterinary Internal Medicine, 35 (4), 1826–1833. https://doi.org/10.1111/jvim.16205

2. Bazil, C. W., Battista, J., & Basner, R. C. (2005). Effects of levetiracetam on sleep in normal volunteers. Epilepsy & Behavior, 7 (3), 539–542. https://doi.org/10.1016/j.yebeh.2005.08.001

3. Bell, C., Vanderlinden, H., Hiersemenzel, R., Otoul, C., Nutt, D., & Wilson, S. (2002). The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy. Journal of Sleep Research, 11 (3), 255–263. https://doi.org/10.1046/j.1365-2869.2002.00301.x

4. Berendt, M., Gredal, H., Pedersen, L. G., Alban, L., & Alving, J. (2002). A cross-sectional study of epilepsy in Danish Labrador retrievers: Prevalence and selected risk factors. Journal of Veterinary Internal Medicine, 16 (3), 262–268. https://doi.org/10.1111/j.1939-1676.2002.tb02367.x

5. Berendt, M., Gulløv, C. H., Christensen, S. L. K., Gudmundsdottir, H., Gredal, H., Fredholm, M., & Alban, L. (2008). Prevalence and characteristics of epilepsy in the Belgian shepherd variants Groenendael and Tervueren born in Denmark 1995–2004. Acta Veterinaria Scandinavica, 50 (1), 51. https://doi.org/10.1186/1751-0147-50-51

6. Carvalho, B. M. S., Chaves, J., & Silva, A. M. d. (2022). Effects of antiepileptic drugs on sleep architecture parameters in adults. Sleep Science, 15 (02), 224–244. https://doi.org/10.5935/1984-0063.20220045

7. Cicolin, A., Magliola, U., Giordano, A., Terreni, A., Bucca, C., & Mutani, R. (2006). Effects of levetiracetam on nocturnal sleep and daytime vigilance in healthy volunteers. Epilepsia, 47 (1), 82–85. https://doi.org/10.1111/j.1528-1167.2006.00376.x

8. De Risio, L., Bhatti, S., Muñana, K., Penderis, J., Stein, V., Tipold, A., Berendt, M., Farqhuar, R., Fischer, A., Long, S., Mandigers, P. J., Matiasek, K., Packer, R. M., Pakozdy, A., Patterson, N., Platt, S., Podell, M., Potschka, H., Batlle, M. P., Rusbridge, C., & Volk, H. A. (2015). International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs. BMC Veterinary Research, 11 (1), 148. https://doi.org/10.1186/s12917-015-0462-1

9. Erlen, A., Potschka, H., Volk, H. A., Sauter-Louis, C., & O’Neill, D. G. (2018). Seizure occurrence in dogs under primary veterinary care in the UK: prevalence and risk factors. Journal of Veterinary Internal Medicine, 32 (5), 1665–1676. https://doi.org/10.1111/jvim.15290

10. Frucht, M. M., Quigg, M., Schwaner, C., & Fountain, N. B. (2000). Distribution of seizure precipitants among epilepsy syndromes. Epilepsia, 41 (12), 1534–1539. https://doi.org/10.1111/j.1499-1654.2000.001534.x

11. Gulløv, C. H., Toft, N., Baadsager, M. M. N., & Berendt, M. (2011). Epilepsy in the Petit Basset Griffon Vendeen: prevalence, semiology, and clinical phenotype. Journal of Veterinary Internal Medicine, 25 (6), 1372–1378. https://doi.org/10.1111/j.1939-1676.2011.00791.x

12. Heske, L., Nødtvedt, A., Jäderlund, K. H., Berendt, M., & Egenvall, A. (2014). A cohort study of epilepsy among 665,000 insured dogs: Incidence, mortality and survival after diagnosis. The Veterinary Journal, 202 (3), 471–476. https://doi.org/10.1016/j.tvjl.2014.09.023

13. Hülsmeyer, V.-I., Fischer, A., Mandigers, P. J. J., DeRisio, L., Berendt, M., Rusbridge, C., Bhatti, S. F. M., Pakozdy, A., Patterson, E. E., Platt, S., Packer, R. M. A., & Volk, H. A. (2015). International veterinary epilepsy task force’s current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs. BMC Veterinary Research, 11 (1). https://doi.org/10.1186/s12917-015-0463-0

14. Kearsley‐Fleet, L., O’Neill, D. G., Volk, H. A., Church, D. B., & Brodbelt, D. C. (2013). Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Veterinary Record, 172 (13), 338. https://doi.org/10.1136/vr.101133

15. Kokkinos, V., Koupparis, A. M., Koutroumanidis, M., & Kostopoulos, G. K. (2022). Editorial: Brain mechanisms linking sleep and epilepsy. Frontiers in Human Neuroscience, 16. https://doi.org/10.3389/fnhum.2022.922372

16. Krishnan, P., Sinha, S., Taly, A. B., Ramachandraiah, C. T., Rao, S., & Satishchandra, P. (2012). Sleep disturbances in juvenile myoclonic epilepsy: A sleep questionnaire-based study. Epilepsy &Amp; Behavior, 23 (3), 305–309. https://doi.org/10.1016/j.yebeh.2011.12.018

17. Legros, B., & Bazil, C. W. (2003). Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Medicine, 4 (1), 51–55. https://doi.org/10.1016/s1389-9457(02)00217-4

18. Malow, B. A., Lin, X., Kushwaha, R., & Aldrich, M. S. (1998). Interictal spiking increases with sleep depth in temporal lobe epilepsy. Epilepsia, 39 (12), 1309–1316. https://doi.org/10.1111/j.1528-1157.1998.tb01329.x

19. Manni, R., & Terzaghi, M. (2010). Comorbidity between epilepsy and sleep disorders. Epilepsy Research, 90 (3), 171–177. https://doi.org/10.1016/j.eplepsyres.2010.05.006

20. Minecan, D., Natarajan, A., Marzec, M., & Malow, B. (2002). Relationship of epileptic seizures to sleep stage and sleep depth. Sleep, 25 (8), 56–61. https://doi.org/10.1093/sleep/25.8.56

21. Mondino, A., Ludwig, C., Menchaca, C., Russell, K., Simon, K. E., Griffith, E., Kis, A., Lascelles, B. D. X., Gruen, M. E., & Olby, N. J. (2023). Development and validation of a sleep questionnaire, SNoRE 3.0, to evaluate sleep in companion dogs. Scientific Reports, 13 (1). https://doi.org/10.1038/s41598-023-40048-1

22. Yuan, X., & Sun, M. (2020). The value of rapid eye movement sleep in the localization of epileptogenic foci for patients with focal epilepsy. Seizure, 81, 192–197. https://doi.org/10.1016/j.seizure.2020.06.009

23. Zhou, J.-Y., Tang, X.-D., Huang, L.-L., Zhong, Z.-Q., Lei, F., & Zhou, D. (2012). The acute effects of levetiracetam on nocturnal sleep and daytime sleepiness in patients with partial epilepsy. Journal of Clinical Neuroscience, 19 (7), 956–960. https://doi.org/10.1016/j.jocn.2011.09.032

Downloads

Published

2026-06-25

How to Cite

Bohdan, A., & Suslova, N. (2026). The impact of idiopathic epilepsy on sleep quality in dogs: A replication study and validation of the SNoRE questionnaire in Ukraine. Scientific Progress & Innovations, 29(1), 261–265. https://doi.org/10.31210/spi2026.29.01.40